Esmolol

Overview

4.7 out of 5 (37 Reviews)

Credits

1.00

Post Assessment Questions

5

Start Date

1 Sep 2023

Last Review Date

30 Jan 2024

Expiration Date

31 Aug 2026

Estimated Time To Finish

60 Minutes


 
Need Help?  If you have a system or content concerns, please contact support@statpearls.com

Activity Description

Esmolol, or esmolol hydrochloride, is an intravenous cardioselective β-1 adrenergic antagonist. This drug has received approval from the United States Food and Drug Administration (FDA) for short-term use in managing supraventricular tachycardia, including rapid ventricular rates in individuals with atrial fibrillation or atrial flutter, and hypertension induced by intubation. Esmolol is a valuable emergency medication for focal atrial tachycardia, particularly in individuals experiencing active bronchospasm. Furthermore, esmolol has proven to be a safe and efficient medication for controlling blood pressure during surgery due to its short half-life. The drug is also indicated in cases of sinus tachycardia, where a rapid heartbeat requires immediate intervention, especially in the case of acute coronary syndrome.

Esmolol is used in various settings, including urgent care, perioperative care, and postoperative care. This drug is used off-label for managing rate and rhythm in conditions such as aortic dissection, acute coronary syndrome, non-ST elevation myocardial infarction, hypertensive emergencies, thyrotoxicosis, refractory ventricular tachycardia, ventricular fibrillation resistant to defibrillation, and for mitigating the catecholamine response during electroconvulsive therapy. This activity focuses on the indications, mechanism of action, adverse events, pharmacology, monitoring, contraindications, clinical toxicology, and relevant interactions of esmolol. This activity also highlights the crucial role of interprofessional healthcare teams involved in assessing treatment approaches and treating patients with tachycardia and related conditions where esmolol is beneficial, considering individual patient needs and potential risk factors.


Target Audience

This activity has been designed to meet the educational needs of physicians, physician associates, nurses, pharmacists, and nurse practitioners.

Learning Objectives

At the conclusion of this activity, the learner will be better able to:

  • Identify the appropriate indications for esmolol use, recognizing scenarios such as supraventricular tachycardia, atrial fibrillation, and hypertensive emergencies.

  • Differentiate between the various clinical settings where esmolol is applicable, including urgent care, perioperative, and emergencies.

  • Assess the patient's response to esmolol, monitoring vital signs, cardiac parameters, and any potential adverse events during treatment.

  • Coordinate with interprofessional healthcare teams to optimize esmolol usage within a comprehensive treatment plan, ensuring seamless integration with other therapeutic modalities and patient-centered care.

Disclosures

StatPearls, LLC requires everyone who influences the content of an educational activity to disclose relevant financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant conflict(s) of interest have been mitigated. Hover over contributor names for financial disclosures. Others involved in planning this educational activity have no relevant financial relationships to disclose.

Commercial Support: This activity has received NO commercial support.

Continuing Education Accreditation Information

In support of improving patient care, StatPearls, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 

Physicians and Physician Associates: StatPearls, LLC designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM. Physicians and PAs should only claim credit commensurate with the extent of their participation in the activity.

American Board of Anesthesiology: This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in AnesthesiologyTM (MOCA®) program, known as MOCA 2.0®. Please consult the ABA website, www.theABA.org, for a list of all MOCA 2.0 requirements.

American Board of Internal Medicine: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

American Board of Pathology: Successful completion of this Continuing Certification activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 Lifelong Learning (CME) credits in the American Board of Pathology’s Continuing Certification Program.

American Board of Pediatrics: Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 1.00 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABP MOC credit.

American Board of Surgery: Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME and Self-Assessment requirement(s) of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

Royal College of Physicians and Surgeons of Canada: Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

Please consult your professional licensing board for information on the applicability and acceptance of continuing education credit for this activity.

Method of Participation and Credit

  1. Register for the activity.    
  2. Review the target audience, learning objectives, and disclosure information.
  3. Study the educational content of the enduring material.
  4. Choose the best answer to each activity test question. To receive credit and a certificate, you must pass the test questions with a minimum score of 100%.
  5. Complete the post-activity assessment survey.

If you have concerns regarding the CE/CME system, please contact support@statpearls.com.

Disclaimer

This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Faculty may discuss investigational products or off-label uses of products regulated by the FDA. Readers should verify all information before employing any therapies described in this educational activity.

The information provided for this activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The information presented does not necessarily reflect the views of StatPearls or any commercial supporters of educational activities on statpearls.com. StatPearls expressly disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through a participant's misunderstanding of the content.

Unapproved Uses of Drugs/Devices: In accordance with FDA requirements, the audience is advised that information presented in this continuing education activity may contain references to unlabeled or unapproved uses of drugs or devices. Please refer to the FDA-approved package insert for each drug/device for full prescribing/utilization information.

Cancellation Policy: Please see the cancellation policy. StatPearls, LLC reserves the right to cancel any course due to unforeseen circumstances.

 

 
 

Reviews

Jason H. on 7/22/2021

Annastasia S. on 11/18/2021

Regina M B. on 3/22/2022

Scott S. on 4/5/2022

Lindsay W. on 4/20/2022

Ehsan Q. on 8/7/2022

Yvonne H. on 8/14/2022

Lauren P. on 9/24/2022

Hardeep A. on 9/27/2022

Kimber E. on 10/18/2022

Terry H. on 11/14/2022

William P. on 11/16/2022

james s. on 12/9/2022

Rene G. on 12/23/2022

Melanie S. on 1/4/2023

Yvonne H. on 2/10/2023

Lily L. on 4/26/2023

Jenna M. on 4/30/2023

Kate K. on 5/2/2023

Jamie K. on 5/19/2023

Elizabeth P. on 8/2/2023

COLLEEN P. on 8/2/2023

SIVA E. on 8/3/2023

MICHAEL F. on 8/8/2023

Eugene V. on 8/10/2023

HILEL S. on 8/15/2023

ANGELO R. on 8/16/2023

Robert D. on 8/16/2023

BRANDON M. on 8/17/2023

Peter K. on 8/22/2023

Charlie C. on 9/11/2023

Douglas P. on 9/27/2023

Cindy D. on 10/13/2023

Tyson B. on 10/18/2023

JOSEPH B. on 11/12/2023

Michael A. on 11/24/2023

Kim L. on 12/15/2023

Unlimited Physician CME

Stay up to date on the latest medical knowledge with 6673 CME activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 7923.5 hours of CME.

Learn About Lifetime CME

Single Activity

Take this single activity

$49 1 activity

6 Month Unlimited Physician CME

Access to all the Unlimited Physician CME activities in all specialties.

$399 per half year per user

1 Year Unlimited Physician CME

Access to all the Unlimited Physician CME activities in all specialties.

$599 per 1 year per user